Geographic access to hematopoietic cell transplantation services in the United States
- PMID: 26457909
- DOI: 10.1038/bmt.2015.246
Geographic access to hematopoietic cell transplantation services in the United States
Abstract
The use of hematopoietic cell transplantation (HCT) has risen in recent years and additional increases are projected in the near- and long-term future. The complex nature of HCT, along with its potentially rigorous follow-up care requirements, presents numerous potential barriers to accessing this important service (for example, financial considerations, donor availability and sociodemographic factors). The distance between a patient and an HCT facility also appears to be an important factor in both HCT use and outcomes. We provide the first comprehensive and detailed evaluation of geographic access to HCT services for the adult (18+ years) and pediatric (0-17 years) populations in the United States. Population-level access is examined as well as detailed gender, race/ethnicity and age breakdowns. Generally, access to HCT services appears to be quite high throughout the United States, as 48%, 78.6% and 94.7% of the 18+ years age population has 30, 90 and 180 min access (respectively) to an adult HCT facility and 42.5%, 72% and 91.5% of the 0-17 years age population has 30, 90 and 180 min access (respectively) to a pediatric facility.
Similar articles
-
Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics.Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):275-280. doi: 10.1182/hematology.2021000259. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889386 Free PMC article. Review.
-
Estimating demand and unmet need for allogeneic hematopoietic cell transplantation in the United States using geographic information systems.J Oncol Pract. 2015 Mar;11(2):e120-30. doi: 10.1200/JOP.2014.000794. J Oncol Pract. 2015. PMID: 25784576 Free PMC article.
-
Challenges around Access to and Cost of Life-Saving Medications after Allogeneic Hematopoietic Cell Transplantation for Medicare Patients.Biol Blood Marrow Transplant. 2017 Aug;23(8):1387-1392. doi: 10.1016/j.bbmt.2017.04.010. Epub 2017 Apr 12. Biol Blood Marrow Transplant. 2017. PMID: 28412517
-
Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.Biol Blood Marrow Transplant. 2020 Dec;26(12):2335-2345. doi: 10.1016/j.bbmt.2020.09.013. Epub 2020 Sep 20. Biol Blood Marrow Transplant. 2020. PMID: 32961375 Free PMC article.
-
The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation.Biol Blood Marrow Transplant. 2010 Feb;16(2):147-56. doi: 10.1016/j.bbmt.2009.08.004. Epub 2009 Sep 30. Biol Blood Marrow Transplant. 2010. PMID: 20142045
Cited by
-
Navigating uncharted waters: assessing the impact of the COVID-19 pandemic on hematopoietic stem cell transplantation: challenges and innovations.Ann Med Surg (Lond). 2024 Aug 7;86(9):5416-5424. doi: 10.1097/MS9.0000000000002442. eCollection 2024 Sep. Ann Med Surg (Lond). 2024. PMID: 39239009 Free PMC article. Review.
-
Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.Haematologica. 2024 Nov 1;109(11):3739-3744. doi: 10.3324/haematol.2023.284584. Haematologica. 2024. PMID: 38618681 Free PMC article. No abstract available.
-
Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy.Cancers (Basel). 2023 Aug 15;15(16):4108. doi: 10.3390/cancers15164108. Cancers (Basel). 2023. PMID: 37627136 Free PMC article. Review.
-
Population-Based Impact of Rurality and Neighborhood-Level Socioeconomic Disadvantage on Pediatric Cancer Mortality in Washington State.Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):141-148. doi: 10.1158/1055-9965.EPI-22-0897. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36343539 Free PMC article.
-
Access to Hematopoietic Stem Cell Transplant in Canada for Patients with Acute Myeloid Leukemia.Curr Oncol. 2022 Jul 22;29(8):5198-5208. doi: 10.3390/curroncol29080412. Curr Oncol. 2022. PMID: 35892981 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
